Alflorex Chewable Tablets – 30 Tablets

Out of stock
Trusted by
50,000+ patients
Free Delivery on
Over £30
UK Registered
Pharmacy
Overview
Alflorex Chewable Tablets bring the same clinically researched Bifidobacterium longum 35624 probiotic strain at the heart of the Alflorex range into a chewable tablet format — making this uniquely evidenced probiotic accessible to those who prefer not to swallow capsules, to those who find a chewable tablet easier to incorporate into their daily routine, and to older children and young adults for whom a palatable chewable is a more practical format than a capsule. The 35624 strain designation — the same as in the Alflorex Capsules — is the critical identifier: it is this specific, patent-protected strain that has been evaluated in multiple double-blind, placebo-controlled clinical trials in IBS patients, not a generic species or an unnamed isolate.
Each chewable tablet provides Bifidobacterium longum 35624 — [CONFIRM CFU count from label] — a naturally resident species of the human large intestine that has been extensively studied for its interactions with gut immune function and its influence on the functional gut discomfort symptoms associated with conditions such as IBS. The clinical evidence for this specific strain is among the strongest available for any commercial probiotic product: landmark published trials (O'Mahony et al., Gastroenterology 2005; Whorwell et al., Am J Gastroenterol 2006) demonstrated significant IBS symptom improvements in patients taking the 35624 strain compared with placebo at matched doses. As a food supplement, Alflorex Chewable Tablets do not claim to treat IBS — but the clinical evidence basis for this strain is genuinely exceptional. [Confirm CFU count, flavour, age guidance, and allergen status from the current product label before publishing.]
Alflorex Chewable Tablets are available from Pearl Chemist Group alongside the Alflorex Capsules — the same clinically evidenced strain in a swallowed capsule format. Browse the full probiotic range at Pearl Chemist Group.
How to Take Alflorex Chewable Tablets – 30 Tablets
Recommended dose: Adults [and children aged — CONFIRM age range from label]: chew 1 tablet daily. Chew the tablet thoroughly before swallowing. [CONFIRM dose from current label.]
Timing: Can be taken at any time of day, with or without food. Taking with or just before a meal provides a food matrix that helps protect the bacteria through the stomach acid environment, supporting the proportion of viable bacteria reaching the large intestine.
Duration: Clinical trials of B. longum 35624 ran for four to eight weeks and demonstrated meaningful effects within this period. Consistent daily use over at least four weeks is recommended before assessing personal benefit. Longer-term ongoing use is appropriate for those who find it beneficial.
Alongside antibiotics: Space at least 2 hours from each antibiotic dose. Continue for at least two to four weeks after completing the antibiotic course to support microbiome recovery.
Storage: Refrigerate after opening if stated on the current label. Do not take with hot drinks — heat reduces bacterial viability.
Key Ingredient in Alflorex Chewable Tablets – 30 Tablets
| Ingredient | Per Tablet | What It Does |
|---|---|---|
| Bifidobacterium longum 35624 | [CONFIRM CFU from label] | A specifically characterised strain of Bifidobacterium longum — a species naturally resident in the human large intestine. The 35624 strain designation precisely identifies the individual isolate studied in multiple double-blind, placebo-controlled clinical trials in IBS patients. Evaluated for its effects on gut immune modulation, intestinal permeability, and functional gut symptom reduction. One of the most extensively clinically studied probiotic strains in any commercially available product. |
[Confirm CFU count — and whether this is guaranteed at manufacture or end-of-shelf-life — from the current product label. Confirm flavour and sweetener details. Confirm dairy allergen status from growth medium.]
Alflorex Chewable Tablets — Dietary & Lifestyle Information
- [Vegetarian — confirm from label; confirm tablet excipients including binding agents and flavourings.]
- [Vegan — confirm from label; confirm all excipients are free from animal-derived ingredients.]
- [Dairy / Milk — B. longum cultures may be grown on dairy media; confirm allergen declaration from current label.]
- [Gluten-Free — confirm from label.]
- [Sweeteners and flavour — confirm sweetener type and flavour from label. Declare for phenylketonuria if aspartame is present.]
- [Age guidance — confirm from label whether suitable for children and from what age.]
- Refrigerate after opening — [CONFIRM from label].
How to Store Alflorex Chewable Tablets – 30 Tablets
Store as directed on the current product label. [CONFIRM whether refrigeration is required throughout or only after opening.] Keep the packaging tightly closed between uses to prevent moisture ingress. Do not take with hot drinks. Do not freeze. Do not use after the expiry date on the packaging. Keep out of reach and sight of children.
Overview
Alflorex Chewable Tablets bring the same clinically researched Bifidobacterium longum 35624 probiotic strain at the heart of the Alflorex range into a chewable tablet format — making this uniquely evidenced probiotic accessible to those who prefer not to swallow capsules, to those who find a chewable tablet easier to incorporate into their daily routine, and to older children and young adults for whom a palatable chewable is a more practical format than a capsule. The 35624 strain designation — the same as in the Alflorex Capsules — is the critical identifier: it is this specific, patent-protected strain that has been evaluated in multiple double-blind, placebo-controlled clinical trials in IBS patients, not a generic species or an unnamed isolate.
Each chewable tablet provides Bifidobacterium longum 35624 — [CONFIRM CFU count from label] — a naturally resident species of the human large intestine that has been extensively studied for its interactions with gut immune function and its influence on the functional gut discomfort symptoms associated with conditions such as IBS. The clinical evidence for this specific strain is among the strongest available for any commercial probiotic product: landmark published trials (O'Mahony et al., Gastroenterology 2005; Whorwell et al., Am J Gastroenterol 2006) demonstrated significant IBS symptom improvements in patients taking the 35624 strain compared with placebo at matched doses. As a food supplement, Alflorex Chewable Tablets do not claim to treat IBS — but the clinical evidence basis for this strain is genuinely exceptional. [Confirm CFU count, flavour, age guidance, and allergen status from the current product label before publishing.]
Alflorex Chewable Tablets are available from Pearl Chemist Group alongside the Alflorex Capsules — the same clinically evidenced strain in a swallowed capsule format. Browse the full probiotic range at Pearl Chemist Group.
How to Take Alflorex Chewable Tablets – 30 Tablets
Recommended dose: Adults [and children aged — CONFIRM age range from label]: chew 1 tablet daily. Chew the tablet thoroughly before swallowing. [CONFIRM dose from current label.]
Timing: Can be taken at any time of day, with or without food. Taking with or just before a meal provides a food matrix that helps protect the bacteria through the stomach acid environment, supporting the proportion of viable bacteria reaching the large intestine.
Duration: Clinical trials of B. longum 35624 ran for four to eight weeks and demonstrated meaningful effects within this period. Consistent daily use over at least four weeks is recommended before assessing personal benefit. Longer-term ongoing use is appropriate for those who find it beneficial.
Alongside antibiotics: Space at least 2 hours from each antibiotic dose. Continue for at least two to four weeks after completing the antibiotic course to support microbiome recovery.
Storage: Refrigerate after opening if stated on the current label. Do not take with hot drinks — heat reduces bacterial viability.
Key Ingredient in Alflorex Chewable Tablets – 30 Tablets
| Ingredient | Per Tablet | What It Does |
|---|---|---|
| Bifidobacterium longum 35624 | [CONFIRM CFU from label] | A specifically characterised strain of Bifidobacterium longum — a species naturally resident in the human large intestine. The 35624 strain designation precisely identifies the individual isolate studied in multiple double-blind, placebo-controlled clinical trials in IBS patients. Evaluated for its effects on gut immune modulation, intestinal permeability, and functional gut symptom reduction. One of the most extensively clinically studied probiotic strains in any commercially available product. |
[Confirm CFU count — and whether this is guaranteed at manufacture or end-of-shelf-life — from the current product label. Confirm flavour and sweetener details. Confirm dairy allergen status from growth medium.]
Alflorex Chewable Tablets — Dietary & Lifestyle Information
- [Vegetarian — confirm from label; confirm tablet excipients including binding agents and flavourings.]
- [Vegan — confirm from label; confirm all excipients are free from animal-derived ingredients.]
- [Dairy / Milk — B. longum cultures may be grown on dairy media; confirm allergen declaration from current label.]
- [Gluten-Free — confirm from label.]
- [Sweeteners and flavour — confirm sweetener type and flavour from label. Declare for phenylketonuria if aspartame is present.]
- [Age guidance — confirm from label whether suitable for children and from what age.]
- Refrigerate after opening — [CONFIRM from label].
How to Store Alflorex Chewable Tablets – 30 Tablets
Store as directed on the current product label. [CONFIRM whether refrigeration is required throughout or only after opening.] Keep the packaging tightly closed between uses to prevent moisture ingress. Do not take with hot drinks. Do not freeze. Do not use after the expiry date on the packaging. Keep out of reach and sight of children.
FAQs
The probiotic strain — Bifidobacterium longum 35624 — and the clinical evidence basis are identical between the two formats. The only difference is administration: the chewable tablets are chewed before swallowing rather than swallowed whole. The chewable format is ideal for those who dislike or cannot comfortably swallow capsules, and may also be more appropriate for older children or young adults depending on the confirmed age guidance on the current label. There is no meaningful clinical difference in efficacy between the two formats when the same dose is consumed.
Bifidobacterium longum 35624 is a specific, precisely characterised probiotic strain — the 35624 designation distinguishes this individual isolate from all other B. longum variants. It was identified and developed by researchers at University College Cork's Alimentary Pharmabiotic Centre and has been studied in multiple double-blind, placebo-controlled clinical trials specifically in patients with IBS. These trials demonstrated statistically significant improvements in overall IBS symptom severity, abdominal bloating, and bowel habit comfort compared with placebo. The precision of the strain designation — to genus, species, and individual strain number — is what sets this product apart from the vast majority of consumer probiotics that cite only species-level evidence.
Alflorex Chewable Tablets are a food supplement — they are not a medicine and do not claim to treat, prevent, or cure IBS. However, the B. longum 35624 strain in these tablets has been studied in clinical trials that specifically enrolled IBS patients, and published results demonstrated meaningful reductions in IBS symptom scores compared with placebo. Many gastroenterologists in the UK are aware of this research. If you have diagnosed IBS, discuss the use of any probiotic supplement with your gastroenterologist or GP before incorporating it into your management approach.
Please confirm the age guidance from the current product label before giving Alflorex Chewable Tablets to a child. The chewable format makes this product more accessible for older children than swallowed capsules, but the appropriate age range should be confirmed from the current label. Consult your GP or paediatric health visitor for guidance on probiotic supplementation for children.
In the clinical trials studying B. longum 35624, meaningful improvements in gut symptoms were observed within four weeks of consistent daily use. Some participants noticed changes earlier; others required the full four-to-eight week study period. Consistent daily use is essential — probiotic effects are cumulative and cannot be assessed meaningfully after only a few days. Expect to take Alflorex consistently for at least four weeks before drawing conclusions about personal benefit.
The single-strain approach reflects the clinical research philosophy of the Alflorex brand. The B. longum 35624 strain has been studied at a validated dose in clinical trials — adding other strains to the formula would make it impossible to attribute any observed benefit specifically to 35624. Single-strain formulations also allow for more consistent manufacturing and quality assurance of the exact dose. The scientific value of the Alflorex proposition depends entirely on the precision of the 35624 strain — a precision that is preserved by its single-strain formulation.
[CONFIRM from current label.] Live bacterial cultures decline more rapidly at room temperature than when refrigerated. If the label recommends refrigeration after opening, store in the refrigerator in the original packaging with the lid tightly closed. Do not freeze. Do not expose tablets to high temperatures or direct sunlight. Keep the packaging sealed between uses to prevent moisture ingress.
Alflorex Chewable Tablets do not have known pharmacological interactions with prescribed medications. However, if you are taking antibiotics, space the Alflorex dose at least 2 hours from each antibiotic dose, as the antibiotic will kill the probiotic bacteria if taken simultaneously. If you are taking prescribed medication for IBS or any gastrointestinal condition, discuss adding Alflorex with your prescribing doctor before starting.